Stock News and Filings Feed
Drug firm Alkem Laboratories is looking to tap domestic as well as international markets for growth going forward, the company has said.
Alkem Laboratories on Friday reported 70 percent fall in net profit to Rs 71.6 crore in the first quarter ended June impacted by destocking of inventory in trade channels on account of GST rollout from July 1.
BSE Telecom index is the top loser on the early hours of Friday’s trade. The index traded lower by 1.56% at 1422.90 level.
Dish TV India informed on Thursday that the company has got the approval of its merger with Videocon D2h from the National Company Law Tribunal (NCLT), for the creation of country’s largest direct-to-home service provider.
10:00 am USFDA nod: Alkem Laboratories shares gained more than 3 percent Monday on zero observations from the US health regulator for Taloja unit.
Key benchmark indices finished last trading day of the week with small losses in a quiet session of trade. The barometer index, the S&P BSE Sensex, fell 16.63 points or 0.05% to settle at 32,020.75. The Nifty index fell 5.35 points or 0.05% to settle at 9,886.35. The Sensex settled above the psychological 32,000 level after alternately swinging above and below that level during the day.
Key benchmark indices provisionally settled with small losses in a quiet session of trade. The barometer index, the S&P BSE Sensex, fell 16.63 points or 0.05% at 32,020.75, as per the provisional closing data. The Nifty index fell 5.35 points or 0.05% at 9,886.35, as per the provisional closing data. The Sensex provisionally settled above the psychological 32,000 level after alternately swinging above and below that level during the day.
New Delhi: The Delhi High Court will today hear the plea filed by several pharmaceutical companies that sought a stay of a central government notification that banned certain fixed dose combination (FDC) drugs.
Mankind Pharmaceuticals, Akum Drugs and JB Chemicals have sought a stay on a government notification banning certain fixed dose combination drugs
Ten pharma stocks fell by 0.07% to 11.22% at 14:00 IST on BSE after a media report indicated likely new US order to lower drug costs in the US.
Alkem Laboratories rallied as much as 2.2 percent and Wockhardt gained 4.5 percent intraday Thursday after companies received drug approvals from the US health regulator
Key benchmark indices extended gains and hit fresh intraday high in mid-afternoon trade. At 14:30 IST, the barometer index, the S&P BSE Sensex, was up 62.26 points or 0.2% at 31,165.75. The Nifty 50 index was up 5.90 points or 0.06% at 9,612.80. Index heavyweights Reliance Industries, ICICI Bank and L&T led the upmove on the domestic bourses. IT stocks fell. Most pharma shares also declined.
Chrys Capital-backed Eris Lifesciences is set to raise Rs 1,800 crore through an IPO which will give an exit to Chrys Capital, which holds around 16.25 percent in the company.
The IPO launch will see private equity investor ChrysCapital sell all of its stake in Eris Lifesciences
Key benchmark indices were range bound in afternoon trade. At 13:19 IST, the barometer index, the S&P BSE Sensex rose 34.93 points or 0.11% at 31,194.33. The Nifty 50 index advanced 10.30 points or 0.11% at 9,634.85.
42Gears, a leading Enterprise Mobility company, recently worked with Alkem Laboratories, one of the biggest Indian pharmaceutical companies to help secure on-field mobile devices from misuse and to enhance workforce productivity.
Key benchmark indices were range bound in afternoon trade. At 13:20 IST, the barometer index, the S&P BSE Sensex was up 48.99 points or 0.16% at 31,158.27. The Nifty 50 index rose 11.50 points or 0.12% at 9,616.40. Hopes of timely arrival of monsoon rains aided small gains on the bourses.
Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.